156 related articles for article (PubMed ID: 10579840)
1. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.
Nagarathnam D; Miao SW; Lagu B; Chiu G; Fang J; Murali Dhar TG; Zhang J; Tyagarajan S; Marzabadi MR; Zhang F; Wong WC; Sun W; Tian D; Wetzel JM; Forray C; Chang RS; Broten TP; Ransom RW; Schorn TW; Chen TB; O'Malley S; Kling P; Schneck K; Bendesky R; Harrell CM
J Med Chem; 1999 Nov; 42(23):4764-77. PubMed ID: 10579840
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.
Murali Dhar TG; Nagarathnam D; Marzabadi MR; Lagu B; Wong WC; Chiu G; Tyagarajan S; Miao SW; Zhang F; Sun W; Tian D; Shen Q; Zhang J; Wetzel JM; Forray C; Chang RS; Broten TP; Schorn TW; Chen TB; O'Malley S; Ransom R; Schneck K; Bendesky R; Harrell CM; Vyas KP
J Med Chem; 1999 Nov; 42(23):4778-93. PubMed ID: 10579841
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
Hancock AA; Buckner SA; Brune ME; Esbenshade TA; Ireland LM; Katwala S; Milicic I; Meyer MD; Kerwin JF; Williams M
J Pharmacol Exp Ther; 2002 Feb; 300(2):478-86. PubMed ID: 11805207
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.
Barrow JC; Nantermet PG; Selnick HG; Glass KL; Rittle KE; Gilbert KF; Steele TG; Homnick CF; Freidinger RM; Ransom RW; Kling P; Reiss D; Broten TP; Schorn TW; Chang RS; O'Malley SS; Olah TV; Ellis JD; Barrish A; Kassahun K; Leppert P; Nagarathnam D; Forray C
J Med Chem; 2000 Jul; 43(14):2703-18. PubMed ID: 10893308
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.
Lagu B; Tian D; Nagarathnam D; Marzabadi MR; Wong WC; Miao SW; Zhang F; Sun W; Chiu G; Fang J; Forray C; Chang RS; Ransom RW; Chen TB; O'Malley S; Zhang K; Vyas KP; Gluchowski C
J Med Chem; 1999 Nov; 42(23):4794-803. PubMed ID: 10579842
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.
Wong WC; Sun W; Lagu B; Tian D; Marzabadi MR; Zhang F; Nagarathnam D; Miao SW; Wetzel JM; Peng J; Forray C; Chang RS; Chen TB; Ransom R; O'Malley S; Broten TP; Kling P; Vyas KP; Zhang K; Gluchowski C
J Med Chem; 1999 Nov; 42(23):4804-13. PubMed ID: 10579843
[TBL] [Abstract][Full Text] [Related]
9. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
[TBL] [Abstract][Full Text] [Related]
10. Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonists.
Witte DG; Brune ME; Katwala SP; Milicic I; Stolarik D; Hui YH; Marsh KC; Kerwin JF; Meyer MD; Hancock AA
J Pharmacol Exp Ther; 2002 Feb; 300(2):495-504. PubMed ID: 11805209
[TBL] [Abstract][Full Text] [Related]
11. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
Brune ME; Katwala SP; Milicic I; Witte DG; Kerwin JF; Meyer MD; Hancock AA; Williams M
J Pharmacol Exp Ther; 2002 Feb; 300(2):487-94. PubMed ID: 11805208
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.
Kuo GH; Prouty C; Murray WV; Pulito V; Jolliffe L; Cheung P; Varga S; Evangelisto M; Wang J
J Med Chem; 2000 Jun; 43(11):2183-95. PubMed ID: 10841797
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.
Lagu B; Tian D; Chiu G; Nagarathnam D; Fang J; Shen Q; Forray C; Ransom RW; Chang RS; Vyas KP; Zhang K; Gluchowski C
Bioorg Med Chem Lett; 2000 Jan; 10(2):175-8. PubMed ID: 10673105
[TBL] [Abstract][Full Text] [Related]
14. NS-49, an alpha 1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs.
Taniguchi N; Hamada K; Ogasawara T; Ukai Y; Yoshikuni Y; Kimura K
Eur J Pharmacol; 1996 Dec; 318(1):117-22. PubMed ID: 9007522
[TBL] [Abstract][Full Text] [Related]
15. (+/-)-Domesticine, a novel and selective alpha1D-adrenoceptor antagonist in animal tissues and human alpha 1-adrenoceptors.
Indra B; Matsunaga K; Hoshino O; Suzuki M; Ogasawara H; Muramatsu I; Taniguchi T; Ohizumi Y
Eur J Pharmacol; 2002 Jun; 445(1-2):21-9. PubMed ID: 12065190
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs.
Brune ME; Katwala SP; Milicic I; Buckner SA; Ireland LM; Kerwin JF; Hancock AA
Pharmacology; 1996 Dec; 53(6):356-68. PubMed ID: 9032800
[TBL] [Abstract][Full Text] [Related]
18. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE
Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730
[TBL] [Abstract][Full Text] [Related]
19. WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.
Bolognesi ML; Budriesi R; Cavalli A; Chiarini A; Gotti R; Leonardi A; Minarini A; Poggesi E; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
J Med Chem; 1999 Oct; 42(20):4214-24. PubMed ID: 10514291
[TBL] [Abstract][Full Text] [Related]
20. Relationship between prostatic alpha(1)-adrenoceptor binding and reduction in intraurethral pressure following continuous infusion of KMD-3213 in rats.
Akiyama K; Tatemichi S; Katayama S; Nakajima M; Oki T; Okura T; Yamada S; Kimura R
Pharmacology; 2002; 64(3):140-7. PubMed ID: 11834890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
